EarLens Corporation
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
EarLens Corporation - overview
Established
2005
Location
Menlo Park, CA, US
Primary Industry
Medical Devices & Equipment
About
EarLens Corporation is a medical technology firm focused on innovative hearing solutions that exceed the capabilities of traditional hearing aids, enhancing sound quality and user experience. EarLens Corporation specializes in advanced hearing solutions, particularly its flagship product, the Earlens Hearing Aid, which uses light-activated lens technology for superior sound delivery. Founded in 2005 and headquartered in Menlo Park, US, the company has completed 13 deals, with its most recent funding occurring on August 20, 2021. In this Series C funding round, EarLens raised USD 21.
23 mn, marking the total amount raised at USD 21. 23 mn. Bill Facteau serves as the CEO. EarLens is dedicated to providing advanced hearing solutions that surpass conventional hearing aids.
Their flagship product, the Earlens Hearing Aid, employs a distinctive light-activated lens technology that conveys sound directly to the eardrum, offering a clearer auditory experience. This device supports individuals with various levels of hearing loss and is available to both adult and pediatric users. Currently, Earlens primarily distributes its products in the United States while also exploring opportunities to enter new international markets. EarLens generates revenue through direct sales of its hearing devices, along with partnerships with audiologists and healthcare providers who assist in distributing its products.
The pricing typically involves a one-time payment that may include customization and ongoing support via a connected app. This model emphasizes direct-to-consumer sales, enabling patients to access their devices through specialized clinics. Financing options are also provided to enhance accessibility for consumers. EarLens Corporation is focusing on future growth through the development of new products and initiatives aimed at expanding into untapped markets.
Following their most recent funding round in August 2021, which raised USD 21. 23 mn, the company aims to introduce innovative hearing solutions that cater to emerging market demands. Specific geographic regions targeted for expansion include international markets experiencing high demand for advanced hearing technologies, with plans to implement these initiatives in the coming years.
Current Investors
New Enterprise Associates, Aisling Capital, Lightstone Ventures
Primary Industry
Medical Devices & Equipment
Sub Industries
Healthcare IT, Medical Devices & Equipment
Website
www.earlenscorp.com
Company Stage
Series C
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.